Skip to Content

P-6101

Main Content

Journal for Immunotherapy of Cancer (JITC) | 2025

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.

Landsburg DJ, Frigault MJ, Heim M, Foley SR, Hill B, Schofield G, Jacobson CA, Jaglowski S, Locke FL, Ram R, Riedell PA, Shah G, Popplewell LL, Tiwari R, Lim S, Majdan M, Masood A, Pasquini MC

PubMed
PMID: 39924174

Abstract
Related Articles

CIBMTR Study #: SC17-08c